Yuan Liu, Qi Pan, Bingran Wang, Aiwei Zhou, Tao Zhou, Yongbo Liu, Yi Luo, Qiang Xia
{"title":"Development of a Survival Predictive Model After Pediatric Liver Transplantation: A Single-center Retrospective Cohort Study.","authors":"Yuan Liu, Qi Pan, Bingran Wang, Aiwei Zhou, Tao Zhou, Yongbo Liu, Yi Luo, Qiang Xia","doi":"10.1097/TP.0000000000005299","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Current prognostic models for liver transplantation (LT) recipients are not applicable for long-term survival prediction, especially for pediatric living donor LT recipients. In this retrospective prognostic study, we aimed to develop and validate a survival predictive model for pediatric LT recipients, the Survival Predictive Model After Pediatric Liver Transplantation (SPPLT) model.</p><p><strong>Methods: </strong>A total of 2964 pediatric recipients from Renji Hospital were enrolled and randomly assigned to the training and validation cohort by a ratio of 1:1. Logistic analysis was performed to identify risk factors for posttransplant mortality and least absolute shrinkage and selection operator Cox regression was used to establish the SPPLT model.</p><p><strong>Results: </strong>Univariate analysis identified 19 risk factors that were associated with post-LT mortality, including graft-recipient compatibility, pre-LT hepatorenal function, blood loss and transfusion during the operation, post-LT infection and surgical complications. Using the least absolute shrinkage and selection operator multivariable Cox regression, we established the prognostic SPPLT model which included 7 clinical easily approached factors (pre-LT creatinine level, blood loss during operation, days of intensive care unit and hospital stay after transplantation, sputum culture positivity, post-LT abdominal hemorrhage, and intestinal perforation). The accuracy of predicting 1-, 3-, and 5-y post-LT survival rates in the training and validation cohort reached 0.802, 0.828, 0.811, and 0.803, 0.784, 0.778, respectively. Furthermore, the SPPLT model efficiently stratified all pediatric LT recipients into high-risk and low-risk groups, which were associated with totally different long-term outcomes (hazard ratio = 0.27, 95% confidence interval (0.120-0.620), P < 0.01).</p><p><strong>Conclusions: </strong>SPPLT is the first prognostic model to accurately predict long-term survival rate after pediatric LT. Recipients with high mortality risk should receive intense monitoring after transplantation.</p>","PeriodicalId":23316,"journal":{"name":"Transplantation","volume":" ","pages":""},"PeriodicalIF":5.3000,"publicationDate":"2025-02-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Transplantation","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1097/TP.0000000000005299","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"IMMUNOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Background: Current prognostic models for liver transplantation (LT) recipients are not applicable for long-term survival prediction, especially for pediatric living donor LT recipients. In this retrospective prognostic study, we aimed to develop and validate a survival predictive model for pediatric LT recipients, the Survival Predictive Model After Pediatric Liver Transplantation (SPPLT) model.
Methods: A total of 2964 pediatric recipients from Renji Hospital were enrolled and randomly assigned to the training and validation cohort by a ratio of 1:1. Logistic analysis was performed to identify risk factors for posttransplant mortality and least absolute shrinkage and selection operator Cox regression was used to establish the SPPLT model.
Results: Univariate analysis identified 19 risk factors that were associated with post-LT mortality, including graft-recipient compatibility, pre-LT hepatorenal function, blood loss and transfusion during the operation, post-LT infection and surgical complications. Using the least absolute shrinkage and selection operator multivariable Cox regression, we established the prognostic SPPLT model which included 7 clinical easily approached factors (pre-LT creatinine level, blood loss during operation, days of intensive care unit and hospital stay after transplantation, sputum culture positivity, post-LT abdominal hemorrhage, and intestinal perforation). The accuracy of predicting 1-, 3-, and 5-y post-LT survival rates in the training and validation cohort reached 0.802, 0.828, 0.811, and 0.803, 0.784, 0.778, respectively. Furthermore, the SPPLT model efficiently stratified all pediatric LT recipients into high-risk and low-risk groups, which were associated with totally different long-term outcomes (hazard ratio = 0.27, 95% confidence interval (0.120-0.620), P < 0.01).
Conclusions: SPPLT is the first prognostic model to accurately predict long-term survival rate after pediatric LT. Recipients with high mortality risk should receive intense monitoring after transplantation.
期刊介绍:
The official journal of The Transplantation Society, and the International Liver Transplantation Society, Transplantation is published monthly and is the most cited and influential journal in the field, with more than 25,000 citations per year.
Transplantation has been the trusted source for extensive and timely coverage of the most important advances in transplantation for over 50 years. The Editors and Editorial Board are an international group of research and clinical leaders that includes many pioneers of the field, representing a diverse range of areas of expertise. This capable editorial team provides thoughtful and thorough peer review, and delivers rapid, careful and insightful editorial evaluation of all manuscripts submitted to the journal.
Transplantation is committed to rapid review and publication. The journal remains competitive with a time to first decision of fewer than 21 days. Transplantation was the first in the field to offer CME credit to its peer reviewers for reviews completed.
The journal publishes original research articles in original clinical science and original basic science. Short reports bring attention to research at the forefront of the field. Other areas covered include cell therapy and islet transplantation, immunobiology and genomics, and xenotransplantation.